Last week over 150 members gathered at Allen and Overy in London for this year’s BIA Committee Summit, to hear updates from the eight BIA Advisory Committees. Find out more in the blog below.
The BIA’s eight Advisory Committees are crucial mechanisms for highlighting the most relevant issues facing bioscience companies, covering areas from cell and gene therapy to intellectual property. Their work informs and guides BIA policy and priorities, ensuring that member needs are met.
Launched at the Summit, the Science and Innovation Advisory Committee (SIAC) is the newest of the BIA committees and was set up to identify and build on evolving science trends in the biotech industry that can give the UK competitive advantage.
The aims of SIAC are to:
- Influence the policy of government and funders of UK science and technology through proactive engagement with key stakeholders to the benefit of UK life science companies
- Encourage active networking between BIA member companies to facilitate communication, collaboration and sharing of best practice for mutual benefit
- Improve translational science through more effective interaction between the academic research community, Tech Transfer Offices and BIA members
- Address the identified science skills shortage in UK life sciences
Dr Mark Carver is the new SIAC Chair and told us the strong UK science base is going to be the catalyst for sector success. SIAC brings together specialists from across the BIA’s membership to help build on this competitive advantage by addressing issues that are key to sector growth, contact us if you want to know more.
Also announced at the Summit, the Synthetic Biology Advisory Committee has been renamed the Engineering Biology Advisory Committee. Speaking at the Summit, Chair of the committee, Dr Tim Fell highlighted how cheap DNA synthesis and new gene editing tools are transforming the biotechnology sector. At the same time, we are seeing increasing numbers of engineers, physicists, and computational scientists joining the field. Engineering biology is a more accessible term that better reflects the breadth of the field and we hope it will encourage potential new members into the committee for 2017.
Finally, the Communications Advisory Committee will be changing and becoming a more informally structured meeting, relaunching as the Communications Forum on Thursday 2 March.
The changes to our Advisory Committees reflect the changing needs of BIA members, who are key to ensuring that these vibrant expert communities can continue to flourish and drive forward sector wide success in 2017.
As part of the Summit, delegates also heard updates from our Cell and Gene Therapy, Finance and Tax, Intellectual Property, Manufacturing and Regulatory Affairs Advisory Committees. Click here to view the slides from the session, with details of all committee activity in 2016 and their areas of focus for 2017.
For more information on the BIA Advisory Committees, please visit the website.
Watch a slideshow of pictures from the day below.